2nd Quarter - Report

FEROX STRATEGIES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

General issues related to patents and access to generics/biosimilars.

LobbyistCovered position, as disclosed
CRISTINA ANTELO New Legal Fellow, Senate Democratic Steering Committee.
DEBRA DIXON —
ZACHARY BENJAMIN FRIEND —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

General issues related to treatment access.

LobbyistCovered position, as disclosed
CRISTINA ANTELO New Legal Fellow, Senate Democratic Steering Committee.
DEBRA DIXON —
ZACHARY BENJAMIN FRIEND —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

General issues related to generic development and commercialization.

LobbyistCovered position, as disclosed
CRISTINA ANTELO New Legal Fellow, Senate Democratic Steering Committee.
DEBRA DIXON —
ZACHARY BENJAMIN FRIEND —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.